Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related α2-macroglobulin-binding protein GRAB located on the bacterial surface

Microbes and Infection

Volumn 9, Issue 8, 2007, Pages 922-931

  Dinkla, Katrin ^a   Sastalla, Inka ^a   Godehardt, Antonia W ^a   Janze, Nina ^a   Chhatwal, Gursharan S ^a   Rohde, Manfred ^a   Medina, Eva ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Antibodies; Capsule; Opsonophagocytosis; Pathogenesis; Streptococcus pyogenes

Indexed keywords

ALPHA 2 MACROGLOBULIN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BINDING PROTEIN; PROTEIN GRAB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL MEMBRANE; CONTROLLED STUDY; FEMALE; HUMAN; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ALPHA-MACROGLOBULINS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BLOOD; CARRIER PROTEINS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; HYALURONIC ACID; MICE; MICE, INBRED C3H; OPSONIN PROTEINS; PHAGOCYTOSIS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); MURINAE; STREPTOCOCCUS PYOGENES;

EID: 34250374044     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.03.011     Document Type: Article

References (25)

1. Efstratiou A. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45 (2000) 3-12
2. Kaplan E.L., and Johnson D.R. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J. Pediatr. 113 (1988) 400-403
3. Massell B.F., Chute C.G., Walker A.M., and Kurland G.S. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N. Engl. J. Med. 318 (1988) 280-286
4. Kaplan E.L., Wotton J.T., and Johnson D.R. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet. 358 (2001) 1334-1337
5. Rasmussen M., Muller H.P., and Bjorck L. Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J. Biol. Chem. 274 (1999) 15336-15344
6. Toppel A.W., Rasmussen M., Rohde M., Medina E., and Chhatwal G.S. Contribution of Protein G-related alpha2-macroglobulin-binding protein to bacterial virulence in a mouse skin model of group A streptococcal infection. J. Infect. Dis. 187 (2003) 1694-1703
7. Siegert J., Sastalla I., Chhatwal G.S., and Medina E. Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci. Microbes Infect. 8 (2006) 347-353
8. Sandin C., Carlsson F., and Lindahl G. Binding of human plasma proteins to Streptococcus pyogenes M-protein determines the location of opsonic and non-opsonic epitopes. Mol. Microbiol. 59 (2006) 20-30
9. Perez-Casal J., Price J.A., Maguin E., and Scott J.R. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol. Microbiol. 8 (1993) 809-819
10. Unnikrishnan M., Cohen J., and Sriskandan S. Growth-phase-dependent expression of virulence factors in an M1T1 clinical isolate of Streptococcus pyogenes. Infect. Immun. 67 (1999) 5495-5499
11. Schrager H.M., Alberti S., Cywes C., Dougherty G.J., and Wessels M.R. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J. Clin. Invest. 101 (1998) 1708-1716
12. Hammerschmidt S., Wolff S., Hocke A., Rosseau S., Muller E., and Rohde M. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect. Immun. 73 (2005) 4653-4667
13. Engleberg N.C., Heath A., Miller A., Rivera C., and DiRita V.J. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J. Infect. Dis. 183 (2001) 1043-1054
14. Gryllos I., Cywes C., Shearer M.H., Cary M., Kennedy R.C., and Wessels M.R. Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol. Microbiol. 42 (2001) 61-74
15. Ravins M., Jaffe J., Hanski E., Shetzigovski I., Natanson-Yaron S., and Moses A.E. Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. J. Infect. Dis. 182 (2000) 1702-1711
16. Wessels M.R., Moses A.E., Goldberg J.B., and DiCesare T.J. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA 88 (1991) 8317-8321
17. Dale J.B., Washburn R.G., Marques M.B., and Wessels M.R. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect. Immun. 64 (1996) 1495-1501
18. Beachey E.H., Seyer J.M., Dale J.B., Simpson W.A., and Kang A.H. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature 292 (1981) 457-459
19. Jones K.F., and Fischetti V.A. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J. Exp. Med. 167 (1988) 1114-1123
20. Schrager H.M., Rheinwald J.G., and Wessels M.R. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Invest. 98 (1996) 1954-1958
21. Toole B.P. Hyaluronan promotes the malignant phenotype. Glycobiology 12 (2002) 37R-42R
22. Collin M., and Olsen A. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J. 20 (2001) 3046-3055
23. Collin M., and Olsen A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect. Immun. 69 (2001) 7187-7189
24. Ashbaugh C.D., Moser T.J., Shearer M.H., White G.L., Kennedy R.C., and Wessels M.R. Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell. Microbiol. 2 (2000) 283-292
25. McArthur J., Medina E., Mueller A., Chin J., Currie B.J., Sriprakash K.S., Talay S.R., Chhatwal G.S., and Walker M.J. Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model. Infect. Immun. 72 (2004) 7342-7347